ESR1 and neoplasm: These data strongly support the notion that the mere detection of an ESR1 transcript or protein expression levels is not sufficient to predict the disease outcome in all tumor samples from different subsites and with different molecular characteristics, especially those that are related to the HPV status, and this obviously represents a limitation of previous studies.